A glucose-responsive alginate-based hydrogel laden with modified GLP-1 and telmisartan ameliorates type 2 diabetes and reduces liver and kidney toxicities

The developed injectable glucose-responsive hydrogel (Diabogel) presents a promising approach for regulating blood glucose levels, restoring pancreatic β cell function, and reducing hepatic and renal toxicities.